Results 211 to 220 of about 163,089 (384)

Cryopreservation and semen quality in patients with Hodgkin's disease [PDF]

open access: bronze, 1995
Mohammad Shekarriz   +5 more
openalex   +1 more source

Impact of age at first visit on glycolipid metabolism, bone metabolism, and fertility potential in patients with Klinefelter syndrome

open access: yesAndrology, EarlyView.
Abstract Background Classic Klinefelter syndrome (KS) is characterized by one extra X chromosome (47, XXY), leading to hypergonadotropic hypogonadism and higher risk of alterations in glycolipid homeostasis, cardiovascular diseases, and low bone mineral density. Most frequently, KS is diagnosed in adulthood because of infertility.
Giordana Ferraioli   +7 more
wiley   +1 more source

Semen quality in patients with testicular cancer is associated with age and with greatly elevated levels of beta human chorionic gonadotropin

open access: yesAndrology, EarlyView.
Abstract Background Poor semen quality is a well‐known feature in patients with testicular germ cell tumours (GCTs) at the time of diagnosis but the underlying biological reasons are incompletely understood. Objectives This study aimed to identify GCT‐specific clinical factors that are involved with poor semen quality in GCT patients.
Klaus‐Peter Dieckmann   +9 more
wiley   +1 more source

The role and implication of platelet‐rich plasma in male factor infertility: A systematic review of human studies

open access: yesAndrology, EarlyView.
Abstract Background Cryopreservation causes sperm injury and the success of surgical sperm retrieval (SSR) for azoospermic men is just over half depending on the cause of azoospermia. The role of autologous platelet‐rich plasma (PRP) in male factor infertility (MFI) is unclear. Objective To conduct a systematic review of the role of PRP in MFI focusing
Karl H. Pang
wiley   +1 more source

Gender‐affirming hormone therapy: Effect on semen quality and use of fertility preservation

open access: yesAndrology, EarlyView.
Abstract Fertility preservation (FP) is a fundamental part of gender care. Gender‐affirming hormone therapy (GAHT) involves the use of drugs that could be potential risk factors for fertility. Therefore, FP is recommended before beginning the gender‐affirmation process.
Anna Chiara Conflitti   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy